Iovance Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinica…

Biotechnology
US, San Carlos [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of IOVA's Analysis
CIK: 1425205 CUSIP: 462260100 ISIN: US4622601007 LEI: - UEI: -
Secondary Listings
IOVA has no secondary listings inside our databases.